| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.991 | 0.002 | 0.991 | Spasmolytic | 0.641 0.01 DBMET03354 | ||
| 0.977 | 0.003 | 0.977 | Toll-Like receptor agonist | 0.957 0.004 DBMET03354 | ||
| 0.977 | 0.003 | 0.977 | Toll-Like receptor 7 agonist | 0.956 0.004 DBMET03354 | ||
| 0.933 | 0.002 | 0.933 | Cholinergic antagonist | 0.449 0.005 DBMET03354 | ||
| 0.926 | 0.002 | 0.926 | Acetylcholine antagonist | 0.437 0.006 DBMET03354 | ||
| 0.896 | 0.001 | 0.896 | Acetylcholine muscarinic antagonist | 0.418 0.005 DBMET03354 | ||
| 0.833 | 0.002 | 0.833 | Acetylcholine M1 receptor antagonist | 0.421 0.005 DBMET03354 | ||
| 0.82 | 0.002 | 0.82 | Anesthetic local | 0.279 0.015 DBMET03354 | ||
| 0.772 | 0.001 | 0.772 | Acetylcholine M3 receptor antagonist | 0.306 0.004 DBMET03354 | ||
| 0.737 | 0.002 | 0.737 | Acetylcholine M2 receptor antagonist | 0.212 0.006 DBMET03354 | ||
| 0.704 | 0.003 | 0.704 | Acetylcholine nicotinic antagonist | 0.126 0.028 DBMET03354 | ||
| 0.604 | 0.004 | 0.604 | Bronchodilator | 0.333 0.008 DBMET03354 | ||
| 0.427 | 0.003 | 0.427 | Acetylcholine M4 receptor antagonist | 0.164 0.009 DBMET03354 | ||
| 0.349 | 0.003 | 0.349 | Acetylcholine muscarinic agonist | |||
| 0.336 | 0.015 | 0.336 | Gastrin inhibitor | 0.297 0.035 DBMET03354 | ||
| 0.327 | 0.007 | 0.327 | Nav1.3 sodium channel blocker | 0.197 0.025 DBMET03354 | ||
| 0.322 | 0.016 | 0.322 | Cholinergic | |||
| 0.306 | 0.005 | 0.306 | Acetylcholine agonist | |||
| 0.351 | 0.064 | 0.625 | Cholesterol antagonist | 0.625 0.015 DBMET03354 | DBMET03354 | |
| 0.284 | 0.004 | 0.284 | Acetylcholine M5 receptor antagonist | 0.156 0.007 DBMET03354 | ||
| 0.267 | 0.011 | 0.267 | Expectorant | 0.21 0.018 DBMET03354 | ||
| 0.378 | 0.125 | 0.41 | Caspase 9 stimulant | 0.41 0.105 DBMET03354 | DBMET03354 | |
| 0.268 | 0.02 | 0.268 | Antipruritic | 0.206 0.045 DBMET03354 | ||
| 0.226 | 0.01 | 0.226 | Calcium antagonist | 0.205 0.013 DBMET03354 | ||
| 0.254 | 0.077 | 0.44 | 5 Hydroxytryptamine uptake stimulant | 0.44 0.008 DBMET03354 | DBMET03354 | |
| 0.214 | 0.041 | 0.214 | Cytidine deaminase inhibitor | |||
| 0.167 | 0.012 | 0.167 | Acetylcholine M3 receptor agonist | |||
| 0.167 | 0.024 | 0.212 | Mucolytic | 0.212 0.011 DBMET03354 | DBMET03354 | |
| 0.215 | 0.072 | 0.281 | Psychostimulant | 0.281 0.048 DBMET03354 | DBMET03354 | |
| 0.13 | 0.005 | 0.13 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.204 | 0.08 | 0.273 | Anticonvulsant | 0.273 0.048 DBMET03354 | DBMET03354 | |
| 0.154 | 0.034 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.176 0.009 DBMET03354 | DBMET03354 | |
| 0.119 | 0.005 | 0.119 | Acetylcholine M2 receptor agonist | |||
| 0.153 | 0.053 | 0.418 | Alpha-N-acetylglucosaminidase inhibitor | 0.418 0.008 DBMET03354 | DBMET03354 | |
| 0.237 | 0.142 | 0.369 | Sodium/bile acid cotransporter inhibitor | 0.369 0.029 DBMET03354 | DBMET03354 | |
| 0.086 | 0.006 | 0.086 | Beta 2 adrenoreceptor agonist | 0.075 0.013 DBMET03354 | ||
| 0.163 | 0.088 | 0.261 | Lipocortins synthesis antagonist | 0.261 0.03 DBMET03354 | DBMET03354 | |
| 0.195 | 0.124 | 0.195 | Cardiotonic | |||
| 0.142 | 0.074 | 0.259 | Protein kinase stimulant | 0.259 0.024 DBMET03354 | DBMET03354 | |
| 0.079 | 0.013 | 0.079 | Opioid kappa receptor agonist | |||
| 0.125 | 0.061 | 0.265 | Cholesterol synthesis inhibitor | 0.265 0.016 DBMET03354 | DBMET03354 | |
| 0.106 | 0.044 | 0.106 | Antineoplastic alkaloid | |||
| 0.229 | 0.172 | 0.423 | Calcium channel activator | 0.423 0.017 DBMET03354 | DBMET03354 | |
| 0.095 | 0.04 | 0.106 | Adrenaline agonist | 0.106 0.033 DBMET03354 | DBMET03354 | |
| 0.107 | 0.053 | 0.149 | Anabolic | 0.149 0.019 DBMET03354 | DBMET03354 | |
| 0.153 | 0.106 | 0.182 | Hepatoprotectant | 0.182 0.078 DBMET03354 | DBMET03354 | |
| 0.106 | 0.061 | 0.545 | GABA C receptor agonist | 0.545 0.003 DBMET03354 | DBMET03354 | |
| 0.19 | 0.154 | 0.39 | Tyrosine 3 hydroxylase inhibitor | 0.39 0.009 DBMET03354 | DBMET03354 | |
| 0.069 | 0.035 | 0.069 | Adrenaline uptake inhibitor | |||
| 0.076 | 0.044 | 0.139 | Glycine receptor agonist | 0.139 0.008 DBMET03354 | DBMET03354 | |
| 0.081 | 0.049 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.048 | 0.022 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.019 DBMET03354 | DBMET03354 | |
| 0.134 | 0.108 | 0.228 | Arachidonic acid antagonist | 0.228 0.013 DBMET03354 | DBMET03354 | |
| 0.077 | 0.053 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET03354 | DBMET03354 | |
| 0.074 | 0.055 | 0.074 | Analgesic, opioid | |||
| 0.065 | 0.049 | 0.065 | Neuronal nicotinic receptor antagonist | |||
| 0.055 | 0.043 | 0.055 | Dopamine uptake inhibitor | 0.051 0.048 DBMET03354 | ||
| 0.057 | 0.049 | 0.057 | Potassium channel (Ca-activated) blocker | |||
| 0.074 | 0.068 | 0.074 | Opioid kappa receptor antagonist | |||
| 0.123 | 0.118 | 0.186 | Adenylate cyclase stimulant | 0.186 0.021 DBMET03354 | DBMET03354 | |
| 0.047 | 0.043 | 0.256 | Aconitate hydratase inhibitor | 0.256 0.003 DBMET03354 | DBMET03354 | |
| 0.111 | 0.112 | 0.151 | Vanilloid 1 agonist | 0.151 0.037 DBMET03354 | DBMET03354 | |
| 0.03 | 0.037 | 0.034 | Tubulin agonist | 0.034 0.025 DBMET03354 | DBMET03354 | |
| 0.051 | 0.065 | 0.059 | Lipocortins synthesis agonist | 0.059 0.039 DBMET03354 | DBMET03354 | |
| 0.014 | 0.03 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.009 DBMET03354 | DBMET03354 | |
| 0.16 | 0.184 | 0.254 | DNA synthesis inhibitor | 0.254 0.064 DBMET03354 | DBMET03354 | |
| 0.104 | 0.129 | 0.157 | Cell wall synthesis inhibitor | 0.157 0.059 DBMET03354 | DBMET03354 | |
| 0.041 | 0.067 | 0.068 | Alpha-mannosidase inhibitor | 0.068 0.019 DBMET03354 | DBMET03354 | |
| 0.033 | 0.06 | 0.085 | Kainate receptor agonist | 0.085 0.003 DBMET03354 | DBMET03354 | |
| 0.018 | 0.045 | 0.031 | Vanilloid 2 agonist | 0.031 0.009 DBMET03354 | DBMET03354 | |
| 0.116 | 0.144 | 0.205 | Interferon gamma antagonist | 0.205 0.039 DBMET03354 | DBMET03354 | |
| 0.128 | 0.16 | 0.197 | Phospholipase C inhibitor | 0.197 0.046 DBMET03354 | DBMET03354 | |
| 0.036 | 0.069 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.081 0.008 DBMET03354 | DBMET03354 | |
| 0.01 | 0.046 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET03354 | DBMET03354 | |
| 0.168 | 0.205 | 0.442 | Transcription factor NF kappa B inhibitor | 0.442 0.054 DBMET03354 | DBMET03354 | |
| 0.054 | 0.095 | 0.13 | Glutamate (mGluR6) antagonist | 0.13 0.005 DBMET03354 | DBMET03354 | |
| 0.025 | 0.067 | 0.093 | GABA uptake inhibitor | 0.093 0.004 DBMET03354 | DBMET03354 | |
| 0.013 | 0.057 | 0.036 | Prostaglandin F2 alpha agonist | 0.036 0.006 DBMET03354 | DBMET03354 | |
| 0.023 | 0.071 | 0.071 | Glutamate (mGluR3) antagonist | 0.071 0.006 DBMET03354 | DBMET03354 | |
| 0.008 | 0.056 | 0.028 | Thromboxane A2 agonist | 0.028 0.004 DBMET03354 | DBMET03354 | |
| 0.024 | 0.074 | 0.068 | Membrane dipeptidase inhibitor | 0.068 0.007 DBMET03354 | DBMET03354 | |
| 0.076 | 0.128 | 0.095 | Toll-Like receptor 4 antagonist | 0.095 0.079 DBMET03354 | DBMET03354 | |
| 0.04 | 0.096 | 0.156 | Leukotriene synthesis inhibitor | 0.156 0.009 DBMET03354 | DBMET03354 | |
| 0.026 | 0.082 | 0.054 | Mannosidase inhibitor | 0.054 0.021 DBMET03354 | DBMET03354 | |
| 0.025 | 0.082 | 0.05 | Glutamate (mGluR8) antagonist | 0.05 0.009 DBMET03354 | DBMET03354 | |
| 0.11 | 0.166 | 0.171 | Pregnane X receptor agonist | 0.171 0.026 DBMET03354 | DBMET03354 | |
| 0.009 | 0.067 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 DBMET03354 | DBMET03354 | |
| 0.019 | 0.079 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET03354 | DBMET03354 | |
| 0.006 | 0.065 | 0.014 | Prostacyclin agonist | 0.014 0.013 DBMET03354 | DBMET03354 | |
| 0.014 | 0.076 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 DBMET03354 | DBMET03354 | |
| 0.036 | 0.099 | 0.165 | Phosphofructokinase-1 inhibitor | 0.165 0.015 DBMET03354 | DBMET03354 | |
| 0.034 | 0.099 | 0.063 | Androgen agonist | 0.063 0.037 DBMET03354 | DBMET03354 | |
| 0.076 | 0.141 | 0.145 | Microtubule formation inhibitor | 0.145 0.04 DBMET03354 | DBMET03354 | |
| 0.009 | 0.077 | 0.052 | Arginase inhibitor | 0.052 0.014 DBMET03354 | DBMET03354 | |
| 0.032 | 0.102 | 0.122 | Carbamoyl phosphate synthetase inhibitor | 0.122 0.015 DBMET03354 | DBMET03354 | |
| 0.021 | 0.093 | 0.05 | Glutamate (mGluR3) agonist | 0.05 0.005 DBMET03354 | DBMET03354 | |
| 0.171 | 0.246 | 0.282 | Interleukin 2 agonist | 0.282 0.088 DBMET03354 | DBMET03354 | |
| 0.055 | 0.13 | 0.086 | Vanilloid 4 agonist | 0.086 0.031 DBMET03354 | DBMET03354 | |
| 0.058 | 0.133 | 0.159 | Prolactin inhibitor | 0.159 0.019 DBMET03354 | DBMET03354 | |
| 0.003 | 0.079 | 0.015 | Thromboxane agonist | 0.015 0.005 DBMET03354 | DBMET03354 | |
| 0.014 | 0.091 | 0.064 | Fumarate hydratase inhibitor | 0.064 0.009 DBMET03354 | DBMET03354 | |
| 0.093 | 0.17 | 0.173 | Sigma receptor agonist | 0.173 0.072 DBMET03354 | DBMET03354 | |
| 0.026 | 0.104 | 0.078 | Beta 2 adrenoreceptor antagonist | 0.078 0.013 DBMET03354 | DBMET03354 | |
| 0.059 | 0.14 | 0.202 | Triose-phosphate isomerase inhibitor | 0.202 0.011 DBMET03354 | DBMET03354 | |
| 0.011 | 0.091 | 0.038 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DBMET03354 | DBMET03354 | |
| 0.027 | 0.109 | 0.158 | Argininosuccinate synthase inhibitor | 0.158 0.011 DBMET03354 | DBMET03354 | |
| 0.037 | 0.126 | 0.09 | Beta adrenoreceptor antagonist | 0.09 0.021 DBMET03354 | DBMET03354 | |
| 0.057 | 0.152 | 0.134 | UDP-glucose 4-epimerase inhibitor | 0.134 0.035 DBMET03354 | DBMET03354 | |
| 0.047 | 0.142 | 0.106 | Glycine receptor antagonist | 0.106 0.027 DBMET03354 | DBMET03354 | |
| 0.057 | 0.152 | 0.218 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.218 0.013 DBMET03354 | DBMET03354 | |
| 0.014 | 0.11 | 0.043 | ATP citrate lysase inhibitor | 0.043 0.011 DBMET03354 | DBMET03354 | |
| 0.152 | 0.248 | 0.271 | Antithrombotic | 0.271 0.11 DBMET03354 | DBMET03354 | |
| 0.043 | 0.141 | 0.142 | Glutamate dehydrogenase inhibitor | 0.142 0.017 DBMET03354 | DBMET03354 | |
| 0.004 | 0.102 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.014 DBMET03354 | DBMET03354 | |
| 0.011 | 0.111 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET03354 | DBMET03354 | |
| 0.024 | 0.124 | 0.053 | Adenylate cyclase 1 inhibitor | 0.053 0.024 DBMET03354 | DBMET03354 | |
| 0.003 | 0.104 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET03354 | DBMET03354 | |
| 0.146 | 0.247 | 0.21 | Vasodilator, coronary | 0.21 0.172 DBMET03354 | DBMET03354 | |
| 0.022 | 0.124 | 0.137 | NMDA 2C receptor antagonist | 0.137 0.008 DBMET03354 | DBMET03354 | |
| 0.01 | 0.113 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.016 DBMET03354 | DBMET03354 | |
| 0.012 | 0.118 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.018 DBMET03354 | DBMET03354 | |
| 0.041 | 0.15 | 0.065 | Ryanodine receptor antagonist | 0.065 0.026 DBMET03354 | DBMET03354 | |
| 0.133 | 0.249 | 0.185 | Peptidyltransferase inhibitor | 0.185 0.12 DBMET03354 | DBMET03354 | |
| 0.01 | 0.127 | 0.032 | Glucocorticoid antagonist | 0.032 0.023 DBMET03354 | DBMET03354 | |
| 0.106 | 0.224 | 0.237 | Neurotrophic factor enhancer | 0.237 0.046 DBMET03354 | DBMET03354 | |
| 0.035 | 0.154 | 0.119 | Aminopeptidase I inhibitor | 0.119 0.02 DBMET03354 | DBMET03354 | |
| 0.087 | 0.209 | 0.121 | Growth hormone agonist | 0.121 0.12 DBMET03354 | DBMET03354 | |
| 0.021 | 0.149 | 0.062 | Glutamate (mGluR8) agonist | 0.062 0.006 DBMET03354 | DBMET03354 | |
| 0.01 | 0.142 | 0.028 | Retinoid X beta receptor antagonist | 0.028 0.005 DBMET03354 | DBMET03354 | |
| 0.054 | 0.191 | 0.104 | Adenylate cyclase inhibitor | 0.104 0.081 DBMET03354 | DBMET03354 | |
| 0.008 | 0.147 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.016 DBMET03354 | DBMET03354 | |
| 0.013 | 0.153 | 0.053 | Guanylate cyclase inhibitor | 0.053 0.018 DBMET03354 | DBMET03354 | |
| 0.117 | 0.259 | 0.225 | 5 Hydroxytryptamine release stimulant | 0.225 0.103 DBMET03354 | DBMET03354 | |
| 0.019 | 0.16 | 0.074 | Acyl-CoA dehydrogenase inhibitor | 0.074 0.025 DBMET03354 | DBMET03354 | |
| 0.058 | 0.2 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.041 DBMET03354 | DBMET03354 | |
| 0.008 | 0.156 | 0.035 | 5-Alpha-reductase inhibitor | 0.035 0.028 DBMET03354 | DBMET03354 | |
| 0.032 | 0.18 | 0.122 | Androgen antagonist | 0.122 0.032 DBMET03354 | DBMET03354 | |
| 0.015 | 0.164 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.018 DBMET03354 | DBMET03354 | |
| 0.024 | 0.173 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 DBMET03354 | DBMET03354 | |
| 0.099 | 0.249 | 0.194 | ATPase inhibitor | 0.194 0.042 DBMET03354 | DBMET03354 | |
| 0.004 | 0.156 | 0.038 | Prostaglandin H2 antagonist | 0.038 0.006 DBMET03354 | DBMET03354 | |
| 0.047 | 0.2 | 0.159 | Cystathionine beta-synthase inhibitor | 0.159 0.037 DBMET03354 | DBMET03354 | |
| 0.039 | 0.192 | 0.185 | Aminopeptidase B inhibitor | 0.185 0.025 DBMET03354 | DBMET03354 | |
| 0.044 | 0.197 | 0.207 | HIV-1 integrase (Overall Integration) inhibitor | 0.207 0.01 DBMET03354 | DBMET03354 | |
| 0.085 | 0.241 | 0.163 | Melanin inhibitor | 0.163 0.066 DBMET03354 | DBMET03354 | |
| 0.007 | 0.167 | 0.067 | Retinoid X receptor agonist | 0.067 0.011 DBMET03354 | DBMET03354 | |
| 0.022 | 0.183 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 DBMET03354 | DBMET03354 | |
| 0.027 | 0.19 | 0.132 | Glutamate decarboxylase inhibitor | 0.132 0.017 DBMET03354 | DBMET03354 | |
| 0.005 | 0.173 | 0.027 | Prostaglandin EP2 agonist | 0.027 0.014 DBMET03354 | DBMET03354 | |
| 0.019 | 0.189 | 0.111 | Biliverdin reductase inhibitor | 0.111 0.016 DBMET03354 | DBMET03354 | |
| 0.049 | 0.218 | 0.081 | MAP kinase kinase 7 inhibitor | 0.081 0.044 DBMET03354 | DBMET03354 | |
| 0.009 | 0.18 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET03354 | DBMET03354 | |
| 0.017 | 0.188 | 0.136 | Alcohol oxidase inhibitor | 0.136 0.012 DBMET03354 | DBMET03354 | |
| 0.034 | 0.21 | 0.072 | Interferon agonist | 0.072 0.066 DBMET03354 | DBMET03354 | |
| 0.058 | 0.235 | 0.14 | Adenylate kinase inhibitor | 0.14 0.03 DBMET03354 | DBMET03354 | |
| 0.046 | 0.226 | 0.101 | Bile acid receptor antagonist | 0.101 0.046 DBMET03354 | DBMET03354 | |
| 0.07 | 0.252 | 0.315 | Anesthetic general | 0.315 0.03 DBMET03354 | DBMET03354 | |
| 0.031 | 0.214 | 0.084 | Glutamate (mGluR7) antagonist | 0.084 0.023 DBMET03354 | DBMET03354 | |
| 0.011 | 0.195 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.031 DBMET03354 | DBMET03354 | |
| 0.021 | 0.21 | 0.057 | Leukotriene B4 antagonist | 0.057 0.031 DBMET03354 | DBMET03354 | |
| 0.029 | 0.218 | 0.071 | Pregnane X receptor antagonist | 0.071 0.013 DBMET03354 | DBMET03354 | |
| 0.056 | 0.246 | 0.156 | Cyclooxygenase 3 inhibitor | 0.156 0.043 DBMET03354 | DBMET03354 | |
| 0.011 | 0.201 | 0.041 | Dopamine D5 agonist | 0.041 0.027 DBMET03354 | DBMET03354 | |
| 0.046 | 0.237 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.032 DBMET03354 | DBMET03354 | |
| 0.055 | 0.248 | 0.138 | Cathepsin H inhibitor | 0.138 0.056 DBMET03354 | DBMET03354 | |
| 0.006 | 0.199 | 0.033 | Prostaglandin agonist | 0.033 0.018 DBMET03354 | DBMET03354 | |
| 0.006 | 0.199 | 0.045 | Glutamate (mGluR1a) agonist | 0.045 0.005 DBMET03354 | DBMET03354 | |
| 0.032 | 0.227 | 0.108 | Ornithine decarboxylase inhibitor | 0.108 0.036 DBMET03354 | DBMET03354 | |
| 0.086 | 0.283 | 0.261 | Succinate dehydrogenase inhibitor | 0.261 0.019 DBMET03354 | DBMET03354 | |
| 0.007 | 0.207 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.038 0.005 DBMET03354 | DBMET03354 | |
| 0.054 | 0.254 | 0.117 | Glutamate (mGluR7) agonist | 0.117 0.033 DBMET03354 | DBMET03354 | |
| 0.037 | 0.237 | 0.133 | Creatine kinase inhibitor | 0.133 0.032 DBMET03354 | DBMET03354 | |
| 0.006 | 0.21 | 0.04 | Free fatty acid receptor 1 antagonist | 0.04 0.015 DBMET03354 | DBMET03354 | |
| 0.034 | 0.238 | 0.059 | Caspase 9 inhibitor | 0.059 0.05 DBMET03354 | DBMET03354 | |
| 0.113 | 0.319 | 0.273 | Vasodilator, peripheral | 0.273 0.111 DBMET03354 | DBMET03354 | |
| 0.029 | 0.236 | 0.133 | GABA aminotransferase inhibitor | 0.133 0.012 DBMET03354 | DBMET03354 | |
| 0.038 | 0.246 | 0.242 | Ferrochelatase inhibitor | 0.242 0.014 DBMET03354 | DBMET03354 | |
| 0.009 | 0.218 | 0.035 | Liver X receptor antagonist | 0.035 0.017 DBMET03354 | DBMET03354 | |
| 0.015 | 0.224 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.013 DBMET03354 | DBMET03354 | |
| 0.053 | 0.263 | 0.13 | Photosensitizer | 0.13 0.047 DBMET03354 | DBMET03354 | |
| 0.046 | 0.255 | 0.095 | Lanosterol 14 alpha demethylase inhibitor | 0.095 0.064 DBMET03354 | DBMET03354 | |
| 0.11 | 0.324 | 0.213 | RNA-directed DNA polymerase inhibitor | 0.213 0.082 DBMET03354 | DBMET03354 | |
| 0.008 | 0.223 | 0.06 | Retinoid X alpha receptor agonist | 0.06 0.011 DBMET03354 | DBMET03354 | |
| 0.02 | 0.235 | 0.111 | Phenylalanine 4-hydroxylase inhibitor | 0.111 0.021 DBMET03354 | DBMET03354 | |
| 0.156 | 0.373 | 0.332 | Calcium channel L-type activator | 0.332 0.131 DBMET03354 | DBMET03354 | |
| 0.102 | 0.32 | 0.183 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.183 0.089 DBMET03354 | DBMET03354 | |
| 0.035 | 0.256 | 0.113 | Keratolytic | 0.113 0.024 DBMET03354 | DBMET03354 | |
| 0.016 | 0.239 | 0.047 | Retinoid X receptor antagonist | 0.047 0.015 DBMET03354 | DBMET03354 | |
| 0.088 | 0.312 | 0.225 | Cyclic AMP phosphodiesterase inhibitor | 0.225 0.077 DBMET03354 | DBMET03354 | |
| 0.018 | 0.243 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.039 DBMET03354 | DBMET03354 | |
| 0.029 | 0.256 | 0.06 | Interferon inducer | 0.06 0.055 DBMET03354 | DBMET03354 | |
| 0.007 | 0.238 | 0.051 | Liver X receptor beta antagonist | 0.051 0.008 DBMET03354 | DBMET03354 | |
| 0.014 | 0.249 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 DBMET03354 | DBMET03354 | |
| 0.009 | 0.245 | 0.097 | NMDA 2A receptor antagonist | 0.097 0.014 DBMET03354 | DBMET03354 | |
| 0.021 | 0.262 | 0.04 | Integrin alpha1beta1 antagonist | 0.04 0.021 DBMET03354 | DBMET03354 | |
| 0.074 | 0.321 | 0.144 | CF transmembrane conductance regulator agonist | 0.144 0.087 DBMET03354 | DBMET03354 | |
| 0.003 | 0.251 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET03354 | DBMET03354 | |
| 0.025 | 0.274 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 DBMET03354 | DBMET03354 | |
| 0.021 | 0.274 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.037 DBMET03354 | DBMET03354 | |
| 0.01 | 0.263 | 0.039 | Glutamate (mGluR1) agonist | 0.039 0.005 DBMET03354 | DBMET03354 | |
| 0.034 | 0.292 | 0.158 | GABA C receptor antagonist | 0.158 0.026 DBMET03354 | DBMET03354 | |
| 0.023 | 0.284 | 0.073 | Dihydroorotate oxidase inhibitor | 0.073 0.015 DBMET03354 | DBMET03354 | |
| 0.04 | 0.304 | 0.142 | Electrolyte absorption antagonist | 0.142 0.023 DBMET03354 | DBMET03354 | |
| 0.045 | 0.315 | 0.156 | DOPA decarboxylase inhibitor | 0.156 0.018 DBMET03354 | DBMET03354 | |
| 0.057 | 0.329 | 0.253 | Interleukin agonist | 0.253 0.077 DBMET03354 | DBMET03354 | |
| 0.045 | 0.317 | 0.136 | Toll-Like receptor 2 antagonist | 0.136 0.063 DBMET03354 | DBMET03354 | |
| 0.058 | 0.334 | 0.36 | Aldehyde oxidase inhibitor | 0.36 0.053 DBMET03354 | DBMET03354 | |
| 0.016 | 0.297 | 0.091 | Histidine decarboxylase inhibitor | 0.091 0.036 DBMET03354 | DBMET03354 | |
| 0.014 | 0.295 | 0.051 | Diacylglycerol O-acyltransferase inhibitor | 0.051 0.034 DBMET03354 | DBMET03354 | |
| 0.006 | 0.295 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.017 DBMET03354 | DBMET03354 | |
| 0.018 | 0.308 | 0.047 | Aldosterone antagonist | 0.047 0.034 DBMET03354 | DBMET03354 | |
| 0.019 | 0.311 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DBMET03354 | DBMET03354 | |
| 0.019 | 0.312 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 DBMET03354 | DBMET03354 | |
| 0.018 | 0.314 | 0.038 | Leukotriene C4 antagonist | 0.038 0.029 DBMET03354 | DBMET03354 | |
| 0.007 | 0.304 | 0.068 | Thromboxane A2 antagonist | 0.068 0.023 DBMET03354 | DBMET03354 | |
| 0.033 | 0.331 | 0.091 | GABA B receptor agonist | 0.091 0.024 DBMET03354 | DBMET03354 | |
| 0.015 | 0.314 | 0.189 | Porphobilinogen synthase inhibitor | 0.189 0.014 DBMET03354 | DBMET03354 | |
| 0.028 | 0.327 | 0.074 | Carbonic anhydrase VI inhibitor | 0.074 0.066 DBMET03354 | DBMET03354 | |
| 0.014 | 0.315 | 0.106 | Catalase inhibitor | 0.106 0.037 DBMET03354 | DBMET03354 | |
| 0.027 | 0.33 | 0.06 | Leukotriene C antagonist | 0.06 0.03 DBMET03354 | DBMET03354 | |
| 0.044 | 0.358 | 0.133 | TRPA1 agonist | 0.133 0.045 DBMET03354 | DBMET03354 | |
| 0.023 | 0.339 | 0.098 | Falcipain 3 inhibitor | 0.098 0.073 DBMET03354 | DBMET03354 | |
| 0.022 | 0.338 | 0.064 | Purinergic P2X1 antagonist | 0.064 0.038 DBMET03354 | DBMET03354 | |
| 0.009 | 0.326 | 0.069 | Thromboxane antagonist | 0.069 0.027 DBMET03354 | DBMET03354 | |
| 0.048 | 0.368 | 0.093 | Glutamate release inhibitor | 0.093 0.054 DBMET03354 | DBMET03354 | |
| 0.031 | 0.353 | 0.112 | GABA C receptor rho-1 antagonist | 0.112 0.048 DBMET03354 | DBMET03354 | |
| 0.011 | 0.34 | 0.057 | Leukotriene antagonist | 0.057 0.055 DBMET03354 | DBMET03354 | |
| 0.128 | 0.46 | 0.481 | Antiinflammatory | 0.481 0.096 DBMET03354 | DBMET03354 | |
| 0.034 | 0.369 | 0.145 | Bone formation stimulant | 0.145 0.063 DBMET03354 | DBMET03354 | |
| 0.095 | 0.434 | 0.144 | Heat shock protein 70 antagonist | 0.144 0.061 DBMET03354 | DBMET03354 | |
| 0.017 | 0.356 | 0.093 | NMDA receptor agonist | 0.093 0.022 DBMET03354 | DBMET03354 | |
| 0.024 | 0.37 | 0.058 | DNA helicase inhibitor | 0.058 0.031 DBMET03354 | DBMET03354 | |
| 0.034 | 0.398 | 0.072 | MDM2 inhibitor | 0.072 0.033 DBMET03354 | DBMET03354 | |
| 0.034 | 0.399 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.045 DBMET03354 | DBMET03354 | |
| 0.055 | 0.426 | 0.406 | Lipoxygenase inhibitor | 0.406 0.036 DBMET03354 | DBMET03354 | |
| 0.031 | 0.406 | 0.131 | Amylase inhibitor | 0.131 0.074 DBMET03354 | DBMET03354 | |
| 0.061 | 0.447 | 0.261 | Superoxide dismutase inhibitor | 0.261 0.068 DBMET03354 | DBMET03354 | |
| 0.085 | 0.474 | 0.262 | GABA C receptor rho-3 antagonist | 0.262 0.144 DBMET03354 | DBMET03354 | |
| 0.015 | 0.405 | 0.052 | Glutamate (mGluR4) antagonist | 0.052 0.019 DBMET03354 | DBMET03354 | |
| 0.027 | 0.418 | 0.102 | Proteasome inhibitor | 0.102 0.084 DBMET03354 | DBMET03354 | |
| 0.038 | 0.431 | 0.257 | Peroxidase inhibitor | 0.257 0.046 DBMET03354 | DBMET03354 | |
| 0.009 | 0.403 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET03354 | DBMET03354 | |
| 0.091 | 0.492 | 0.182 | Nitric-oxide synthase stimulant | 0.182 0.123 DBMET03354 | DBMET03354 | |
| 0.004 | 0.42 | 0.07 | NMDA 2 receptor antagonist | 0.07 0.052 DBMET03354 | DBMET03354 | |
| 0.035 | 0.451 | 0.084 | ABCA1 expression enhancer | 0.084 0.077 DBMET03354 | DBMET03354 | |
| 0.043 | 0.461 | 0.125 | GABA C receptor rho-2 antagonist | 0.125 0.116 DBMET03354 | DBMET03354 | |
| 0.072 | 0.492 | 0.296 | Insulysin inhibitor | 0.296 0.061 DBMET03354 | DBMET03354 | |
| 0.099 | 0.53 | 0.402 | 5 Hydroxytryptamine release inhibitor | 0.402 0.077 DBMET03354 | DBMET03354 | |
| 0.007 | 0.439 | 0.064 | NMDA receptor glycine site agonist | 0.064 0.042 DBMET03354 | DBMET03354 | |
| 0.009 | 0.452 | 0.058 | Thromboxane synthase inhibitor | 0.058 0.03 DBMET03354 | DBMET03354 | |
| 0.022 | 0.47 | 0.118 | Nav1.6 sodium channel blocker | 0.118 0.099 DBMET03354 | DBMET03354 | |
| 0.041 | 0.493 | 0.077 | CC chemokine 5 receptor agonist | 0.077 0.075 DBMET03354 | DBMET03354 | |
| 0.063 | 0.516 | 0.171 | Neurotensin receptor agonist | 0.171 0.06 DBMET03354 | DBMET03354 | |
| 0.06 | 0.513 | 0.302 | Histamine release inhibitor | 0.302 0.122 DBMET03354 | DBMET03354 | |
| 0.099 | 0.554 | 0.164 | 5 Hydroxytryptamine 3E antagonist | 0.164 0.158 DBMET03354 | DBMET03354 | |
| 0.027 | 0.49 | 0.164 | Insulin sensitizer | 0.164 0.115 DBMET03354 | DBMET03354 | |
| 0.027 | 0.505 | 0.116 | Aldehyde dehydrogenase inhibitor | 0.116 0.076 DBMET03354 | DBMET03354 | |
| 0.011 | 0.491 | 0.045 | Glutamate (mGluR group III) agonist | 0.045 0.028 DBMET03354 | DBMET03354 | |
| 0.115 | 0.609 | 0.284 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.284 0.235 DBMET03354 | DBMET03354 | |
| 0.046 | 0.548 | 0.164 | Sphingosine 1-phosphate receptor 5 antagonist | 0.164 0.04 DBMET03354 | DBMET03354 | |
| 0.009 | 0.536 | 0.088 | 5-Lipoxygenase inhibitor | 0.088 0.073 DBMET03354 | DBMET03354 | |
| 0.022 | 0.56 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.072 DBMET03354 | DBMET03354 | |
| 0.008 | 0.587 | 0.083 | Alcohol dehydrogenase inhibitor | 0.083 0.075 DBMET03354 | DBMET03354 | |
| 0.02 | 0.609 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.1 DBMET03354 | DBMET03354 | |
| 0.012 | 0.623 | 0.098 | Caspase 3 inhibitor | 0.098 0.095 DBMET03354 | DBMET03354 | |
| 0.021 | 0.636 | 0.149 | Non-steroidal antiinflammatory agent | 0.149 0.116 DBMET03354 | DBMET03354 | |
| 0.03 | 0.655 | 0.179 | Neuropeptide Y2 antagonist | 0.179 0.161 DBMET03354 | DBMET03354 | |
| 0.022 | 0.688 | 0.221 | Hypoxia-inducible factor 1 alpha inhibitor | 0.221 0.128 DBMET03354 | DBMET03354 | |
| 0.004 | 0.929 | 0.118 | Cyclooxygenase inhibitor | 0.118 0.102 DBMET03354 | DBMET03354 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |